The Role of Diagnostics in Achieving Health-For-All

This morning, we heard from Chris L. Hardesty, Director of KPMG Singapore Life Science Practice, about the design of “health-for-all” valued-based programs in the region and the evolving role for diagnostics companies, as well as from Nadine Brun, Managing Director at bioMérieux about new innovations in key #healthcare challenges. Sincere thanks to our speakers and participants who attended the session!


Support the business community through our COVID-19 Collaborative Platform!